MAP PHARMACEUTICALS, INC. Increase (Decrease) in Accrued Liabilities
MAP PHARMACEUTICALS, INC. reported Increase (Decrease) in Accrued Liabilities of $7.09 million for the 111-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2012-11-06
- MAP PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for the quarter ending 2012-09-30 was $418.00K, a 45.07% decline year-over-year.
- MAP PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for the quarter ending 2012-06-30 was $678.00K.
- MAP PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for the quarter ending 2012-03-31 was -$863.00K.
- MAP PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for the quarter ending 2011-12-31 was $846.00K, a 10.38% decline year-over-year.
- MAP PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for fiscal 2011 was -$2.51M.
- MAP PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for fiscal 2010 was -$2.13M.
- MAP PHARMACEUTICALS, INC. increase (decrease) in accrued liabilities for fiscal 2009 was -$3.92M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 96 month | Increase (Decrease) in Accrued Liabilities 99 month | Increase (Decrease) in Accrued Liabilities 102 month | Increase (Decrease) in Accrued Liabilities 105 month | Increase (Decrease) in Accrued Liabilities 108 month | Increase (Decrease) in Accrued Liabilities 111 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $418.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $1.10M derived: sum of 2 quarters · filed 2012-11-06 | $233.00K 10-Q · filed 2012-11-06 | $1.08M derived: sum of 4 quarters · filed 2012-11-06 | $7.09M 10-Q · filed 2012-11-06 | |||||
| 2012-06-30 | $678.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | -$185.00K 10-Q · filed 2012-07-27 | $661.00K derived: sum of 3 quarters · filed 2012-07-27 | $1.42M derived: sum of 4 quarters · filed 2012-11-06 | $6.67M 10-Q · filed 2012-07-27 | |||||
| 2012-03-31 | -$863.00K 10-Q · filed 2012-05-08 | -$17.00K derived: sum of 2 quarters · filed 2012-05-08 | $744.00K derived: sum of 3 quarters · filed 2012-11-06 | $254.00K derived: sum of 4 quarters · filed 2012-11-06 | $5.99M 10-Q · filed 2012-05-08 | |||||
| 2011-12-31 | $846.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $1.61M derived: sum of 2 quarters · filed 2012-11-06 | $1.12M derived: sum of 3 quarters · filed 2012-11-06 | -$2.51M 10-K · filed 2012-03-30 | $6.85M 10-K · filed 2012-03-30 | |||||
| 2011-09-30 | $761.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $271.00K derived: sum of 2 quarters · filed 2012-11-06 | -$3.35M 10-Q · filed 2012-11-06 | -$2.41M derived: sum of 4 quarters · filed 2012-11-06 | $6.01M 10-Q/A · filed 2012-03-30 | |||||
| 2011-06-30 | -$490.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | -$4.12M 10-Q · filed 2012-07-27 | -$3.17M derived: sum of 3 quarters · filed 2012-07-27 | -$3.11M derived: sum of 4 quarters · filed 2012-07-27 | $5.25M 10-Q/A · filed 2012-03-30 | |||||
| 2011-03-31 | -$3.63M 10-Q · filed 2012-05-08 | -$2.68M derived: sum of 2 quarters · filed 2012-05-08 | -$2.62M derived: sum of 3 quarters · filed 2012-05-08 | |||||||
| 2010-12-31 | $944.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30 | $1.01M derived: sum of 2 quarters · filed 2012-03-30 | -$2.13M 10-K · filed 2012-03-30 | |||||||
| 2010-09-30 | $64.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-30 | -$3.07M 10-Q/A · filed 2012-03-30 | ||||||||
| 2010-06-30 | -$3.14M 10-Q/A · filed 2012-03-30 | |||||||||
| 2009-12-31 | -$3.92M 10-K · filed 2012-03-30 |